The Neurological Foundation announces July 2016 Grant Round Recipients
The Neurological Foundation launches its Annual Appeal week with a commitment of over $1.3 million to brain research funding in the July grant round.
The Neurological Foundation is pleased to announce that funding of $1,340,602 for neurological research projects, a clinical research fellowship, a repatriation fellowship and travel grants has been approved in its July 2016 grant round. The Neurological Foundation is the primary non-government sponsor of neurological research in New Zealand, and Annual Appeal week runs from Sunday 3 July through to Saturday 9 July.
Neurological Foundation Executive Director Max Ritchie says “This grant round illustrates the breadth of brain research in New Zealand as it continues to contribute to and progress global knowledge of neurological disorders. Many of the projects in this round involve collaborations of New Zealand’s brain research leaders; being able to fund highly innovative research is both gratifying and exciting, and we thank our donors for their continued commitment as we work towards improving outcomes for the hundreds of thousands of people living with neurological disorders in New Zealand. We would be very grateful for additional support from the public during our Annual Appeal week.
In this round, young New Zealand neurologist Dr Jenny Taylor has been awarded the 2016 Neurological Foundation V J Chapman Clinical Research Fellowship to study autoantibodies in autoimmune encephalitis at John Radcliffe Hospital in Oxford. Dr Taylor will return to New Zealand after her research year.
The 2016 Neurological Foundation Repatriation Fellowship will bring neuroscientist Dr Juliette Cheyne home to the University of Auckland to investigate how auditory cortex development affects Autism Spectrum Disorders. Dr Cheyne is currently a postdoctoral fellow at the Netherlands Institute for Neuroscience.
The July grants allocated include the funding of the following projects which will be carried out at the University of Auckland, the University of Otago Christchurch and the University of Otago:
- Epilepsy: A proof-of-principle study of a tailor-made, intranasal anti-convulsant drug carrier system
- Fragile X Syndrome: Developing an authentic research model of Fragile X Syndrome using an innovative New Zealand-developed technology
- Multiple sclerosis: Can a new drug-delivery system specifically target lesions in a model of multiple sclerosis to improve brain function?
- Parkinson’s disease: Investigating the role of sub-thalamic nucleus activity in impulsivity in a model using optogenetic technology
- Alzheimer’s disease: The investigation of a neuroprotective protein’s potential to rescue memory function
- Epilepsy: A laboratory based study to determine reliable methods for examining the effect of cannabidiol in epilepsy
- Brain function: Investigating the mechanisms of proteins in oxidative stress in brain disorders
- Stroke: Investigating a new approach to brain stimulation in a model of stroke to optimise recovery
- Traumatic brain injury: Development of a skin/skull/brain model to measure impact forces to the head and brain-injury mechanisms
- Schizophrenia and ADHD-like hyperactivity: Measuring changes in brain circuitry to increase knowledge of the anatomical basis of schizophrenia and ADHD-like hyperactivity
The Neurological Foundation would like to acknowledge the remarkable support of Mitre 10 staff and customers nationally and record that this year marks a 25-year partnership. Thank you Mitre 10!